News
2h
24/7 Wall St. on MSNBig-Name Analyst Just Went Cold on Starbucks. It’s Time to Buy This DipKey Points Starbucks faces an uphill battle as macro headwinds stand to worsen. A big analyst over at TD Cowen recently ...
Cheaper hardware, AI advances and early adoption are turning a decade of promises into something more tangible. As Tesla’s ...
But after Campbell's (CPB) third-fiscal-quarter results on Monday, analysts now say the company's snacks division - home to Goldfish - is holding it back, as anxieties related to tariffs and inflation ...
Marc Frahm, an analyst at TD Cowen, downgraded Blueprint Medicines Corporation (NASDAQ:BPMC) from Buy to Hold. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results